Calcium Lactate Encyclopedia — Scientific Background

What Is Calcium Lactate?

Calcium lactate (CAS 814-80-2), also known as calcium 2-hydroxypropanoate or calcium dilactate, is the calcium salt of lactic acid. It is chemically characterized by the molecular formula C₆H₁₀CaO₆ (anhydrous) and a molecular weight of 218.22 g/mol. The compound exists in several hydrate forms, with the pentahydrate form having a molecular weight of 308.29 g/mol. It is a white, nearly odorless, crystalline powder or granule that is soluble in water (approximately 9 g/100 mL at 25°C) and practically insoluble in ethanol. Calcium lactate contains 13.1%–14.5% elemental calcium and is a food additive with the E number E327 and INS number 327.

Regulatory Status and Pharmacopoeial Standards

Calcium lactate holds a well-established regulatory position as both a pharmaceutical and food ingredient:

FDA GRAS Status — Calcium lactate is affirmed as Generally Recognized As Safe (GRAS) by the FDA under 21 CFR 184.1207 for use as a direct human food ingredient with no limitation other than current good manufacturing practice. The FDA Substances Added to Food database lists calcium lactate with CAS Registry No. 814-80-2 and identifies its technical effects as dough strengthener, firming agent, flavor enhancer, flavoring agent or adjuvant, leavening agent, malting or fermenting aid, nutrient supplement, pH control agent, and stabilizer or thickener.

Food Additive — Calcium lactate functions as an acidity regulator, antioxidant, emulsifier, firming agent, stabilizer, and thickener with the E number E327 and INS number 327. It is permitted in food with no maximum level (quantum satis) in the European Union for processed cereal-based foods and baby foods for pH adjustment (L(+)-form only).

Global Standards — Calcium lactate conforms to the Food Chemicals Codex (FCC), European Pharmacopoeia, Joint FAO/WHO Expert Committee on Food Additives (JECFA) specifications, and Chinese national standard GB 2760-2024, which permits its use in processed fruits, frozen fruits, dried fruits, fruit preserves, jams, and other food categories at appropriate levels according to production needs.

Physiological Functions of Calcium

Calcium is the most abundant mineral in the human body, with approximately 99% stored in bones and teeth as hydroxyapatite complexes. Key physiological roles include:

• Bone Structure — Calcium provides strength and structure to bones and teeth

• Muscle Contraction — Calcium triggers the interaction between actin and myosin filaments necessary for muscle movement

• Nerve Transmission — Calcium ions are essential for neurotransmitter release at synaptic junctions

• Blood Clotting — Calcium is a cofactor for multiple clotting factors in the coagulation cascade

• Cardiovascular Function — Calcium regulates heart rhythm and vascular tone

• Hormone Secretion — Calcium signaling is required for the release of various hormones

Mechanisms of Action and Absorption

Conventional Calcium Absorption Pathway

Intestinal calcium absorption occurs through two distinct mechanisms:

Transcellular Absorption — An active, energy-dependent process that takes place primarily in the duodenum. It is dependent on the concentration of calcium-binding proteins and is rapidly saturable. This pathway requires active vitamin D.

Paracellular Absorption — A passive, energy-independent process that occurs throughout the intestine. It is independent of calcium concentration in the gut lumen and is not rapidly saturable. This pathway is not vitamin D dependent.

Calcium lactate is absorbed via the paracellular pathway, which does not require stomach acid for dissolution. This is why calcium lactate is absorbed equally well with or without food and is the preferred form for individuals with hypochlorhydria or those taking acid-reducing medications.

liposomal Absorption Pathway

Liposomal encapsulation provides a fundamentally different absorption mechanism. liposomes protect active ingredients from being destroyed by gastric acid and digestive enzymes. Due to their affinity with cell membranes, active substances can penetrate the intestinal wall more efficiently and enter the bloodstream and cells directly. Encapsulation within liposomal vesicles enhanced calcium delivery to target cells, increasing intracellular calcium and stimulating downstream physiological responses.

Calcium and Glycemic Control

Intracellular calcium in pancreatic beta cells plays a crucial role in insulin synthesis and secretion. Diabetes impairs this calcium-mediated action, necessitating an effective delivery system such as liposomes to facilitate calcium uptake. Calcium lactate nanoliposomes significantly reduced blood glucose levels in diabetic and glucose-loaded mice, with pancreatic calcium concentrations higher in animals receiving calcium nanoliposomes compared to controls.

Liposomal calcium lactate

Liposomal encapsulation of calcium lactate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the calcium-lactate complex, forming a protective shell that enhances absorption and enables targeted delivery. This delivery system:

• Protects calcium from gastric acid degradation and dietary inhibitors

• Enhances intestinal absorption through lipid-mediated pathways

• Provides sustained release with prolonged calcium elevation

• Minimizes direct contact between calcium and the gastrointestinal mucosa

• Achieves 93.42% encapsulation efficiency with stable pH and particle size over six cycles

Calcium lactate nanoliposomes (6.25 mg/mL) were prepared via the thin-film hydration method using lecithin and cholesterol as bilayer lipids. The nanoliposomes exhibited a diameter of 172.1 nm, zeta potential of −53.45 mV, polydispersity index of 0.203, and pH 7.2.

Clinical Evidence

Calcium Deficiency States

Calcium lactate tablets are indicated for the treatment of calcium deficiency states as a therapeutic supplement in pregnancy, lactation, osteoporosis, post-gastrectomy malabsorption, osteomalacia, and rickets. The standard adult dose including elderly is 300–600 mg daily (1–2 tablets), with pregnant women during the third trimester and lactation requiring 0.9–1.2 g daily (3–4 tablets).

Glycemic Control — Preclinical Evidence

A study published in 2025 evaluated calcium lactate nanoliposomes for glycemic control in a mouse diabetes mellitus model. Calcium lactate nanoliposomes (6.25 mg/mL) were prepared via the thin-film hydration method using lecithin and cholesterol as bilayer lipids. Treatment with calcium nanoliposomes significantly reduced blood glucose levels in both diabetic and glucose-loaded mice. Pancreatic calcium concentrations were higher in animals receiving calcium nanoliposomes compared to controls. Encapsulation within liposomal vesicles enhanced calcium delivery to pancreatic beta cells, increasing intracellular calcium and stimulating insulin production and release, corroborated by elevated pancreatic calcium levels observed via X-ray fluorescence in treated animals.

Food Fortification

Calcium lactate is widely used for calcium supplementation and texture improvement in food and beverages. It is permitted for use in processed fruits, frozen fruits, dried fruits, fruit preserves, jams, and other food categories at appropriate levels according to production needs. It is also used in meat and poultry products at levels up to 6,000 mg/kg.

Safety and Regulatory

Calcium lactate is generally well tolerated. The most common side effect is constipation, though this is less frequent with calcium lactate than with calcium carbonate due to its superior solubility and gastrointestinal tolerability. The Tolerable Upper Intake Level (UL) for elemental calcium is 2,500 mg/day for adults aged 19–50 years and 2,000 mg/day for adults aged 51 years and older.

Calcium lactate should not be taken for long periods without medical advice. Contraindications include severe hypercalcemia and hypercalciuria (e.g., hypervitaminosis D, hyperparathyroidism, severe renal failure, osteoporosis due to immobility, and decalcifying tumors). Patients receiving therapy with cardiac glycosides such as digoxin must not be given calcium supplements. Calcium salts should be administered with caution to patients with impaired renal function, cardiac disease, or sarcoidosis.

Calcium lactate is widely commercialized as a dietary supplement ingredient, pharmaceutical agent, and food additive. It is Generally Recognized As Safe (GRAS) by the FDA under 21 CFR 184.1207 and is an authorized food additive (E327) in the European Union. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, FAO/WHO JECFA, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

59$/KG